121 related articles for article (PubMed ID: 1412222)
1. Arterial thrombosis model with photochemical reaction in guinea-pig and its property.
Takiguchi Y; Hirata Y; Wada K; Nakashima M
Thromb Res; 1992 Aug; 67(4):435-45. PubMed ID: 1412222
[TBL] [Abstract][Full Text] [Related]
2. Vessel wall injury and arterial thrombosis induced by a photochemical reaction.
Saniabadi AR; Umemura K; Matsumoto N; Sakuma S; Nakashima M
Thromb Haemost; 1995 May; 73(5):868-72. PubMed ID: 7482418
[TBL] [Abstract][Full Text] [Related]
3. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model.
Matsuno H; Uematsu T; Nagashima S; Nakashima M
J Pharmacol Methods; 1991 Jul; 25(4):303-17. PubMed ID: 1909407
[TBL] [Abstract][Full Text] [Related]
4. Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator.
Matsuno H; Uematsu T; Umemura K; Takiguchi Y; Wada K; Nakashima M
Br J Pharmacol; 1992 Jul; 106(3):533-8. PubMed ID: 1387025
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of a novel orally active GP IIb/IIIa inhibitor, SC-54684A on intimal thickening in the guinea pig femoral artery.
Umemura K; Nishiyama H; Kikuchi S; Kondo K; Nakashima M
Thromb Haemost; 1996 Nov; 76(5):799-806. PubMed ID: 8950793
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of clopidogrel, vapiprost and argatroban on the middle cerebral artery thrombosis in the rat.
Umemura K; Kawai H; Ishihara H; Nakashima M
Jpn J Pharmacol; 1995 Mar; 67(3):253-8. PubMed ID: 7630043
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of thrombolytic efficacy of tissue-type plasminogen activator by adjuvants in the guinea pig thrombosis model.
Nishiyama H; Umemura K; Saniabadi AR; Takiguchi Y; Uematsu T; Nakashima M
Eur J Pharmacol; 1994 Oct; 264(2):191-8. PubMed ID: 7851482
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antithrombotic effects of GPIIb-IIIa receptor antagonist and TXA2 receptor antagonist in the guinea-pig thrombosis model: possible role of TXA2 in reocclusion after thrombolysis.
Takiguchi Y; Asai F; Wada K; Nakashima M
Thromb Haemost; 1995 Apr; 73(4):683-8. PubMed ID: 7495079
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the inhibitory effects of the TXA2 receptor antagonist, vapiprost, and other antiplatelet drugs on arterial thrombosis in rats: possible role of TXA2.
Takiguchi Y; Wada K; Nakashima M
Thromb Haemost; 1992 Oct; 68(4):460-3. PubMed ID: 1448780
[TBL] [Abstract][Full Text] [Related]
10. Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig.
Hirata Y; Takiguchi Y; Wada K; Matsuno H; Umemura K; Uematsu T; Nakashima M
Eur J Pharmacol; 1993 Feb; 231(3):421-5. PubMed ID: 8449234
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model.
Imura Y; Kiyota Y; Nagai Y; Nishikawa K; Terashita Z
Thromb Res; 1995 Jul; 79(1):95-107. PubMed ID: 7495108
[TBL] [Abstract][Full Text] [Related]
12. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M
Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding.
Kawano KI; Hokamura K; Kondo K; Ikeda Y; Suzuki Y; Umemura K
Eur J Pharmacol; 2001 Apr; 417(3):217-22. PubMed ID: 11334853
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the antithrombotic effect of aurintricarboxylic acid on arterial thrombosis in rats and guinea pigs.
Takiguchi Y; Shimazawa M; Nakashima M
Br J Pharmacol; 1996 Aug; 118(7):1633-8. PubMed ID: 8842425
[TBL] [Abstract][Full Text] [Related]
15. Experimental thrombosis model induced by free radicals. Application to aspirin and other different substances.
Jourdan A; Aguejouf O; Imbault P; Doutremepuich F; Inamo J; Doutremepuich C
Thromb Res; 1995 Jul; 79(1):109-23. PubMed ID: 7495098
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of KW-3635, a new thromboxane A2-receptor antagonist, on arterial thrombosis in guinea pigs.
Higo K; Karasawa A
Jpn J Pharmacol; 1993 Dec; 63(4):521-3. PubMed ID: 8121085
[TBL] [Abstract][Full Text] [Related]
17. Dietary antioxidative potential in arteries.
Rilantono LI; Yuwono HS; Nugrahadi T
Clin Hemorheol Microcirc; 2000; 23(2-4):113-7. PubMed ID: 11321428
[TBL] [Abstract][Full Text] [Related]
18. Effect of dietary docosahexaenoic acid in the rat middle cerebral artery thrombosis model.
Umemura K; Toshima Y; Asai F; Nakashima M
Thromb Res; 1995 Jun; 78(5):379-87. PubMed ID: 7660354
[TBL] [Abstract][Full Text] [Related]
19. Photochemically induced thrombosis of the rat coronary artery and functional evaluation of thrombus formation by occurrence of ventricular arrhythmias. Effects of acetylsalicylic acid and a thromboxane A2 synthetase inhibitor of thrombus formation.
Fukuchi M; Uematsu T; Araki S; Nakashima M
Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):550-4. PubMed ID: 1470226
[TBL] [Abstract][Full Text] [Related]
20. Role of thromboxane A2 in a microcirculation disorder of the rat inner ear.
Umemura K; Asai Y; Uematsu T; Nakashima M
Eur Arch Otorhinolaryngol; 1993; 250(6):342-4. PubMed ID: 8260145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
